Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofigo ...
The RSC Radiochemistry Group are pleased to present the second Radionuclide Production in the UK meeting, co-hosted with National Physical Laboratory (NPL). The meeting will explore the current status ...
Learning Objectives Cyclotrons are currently used for the preparation of a wide variety of radionuclides that find application in positron emission tomography (PET) as well as in single photon ...
Use the facets to input your search criteria or the text field to search by title, keyword, ISBN, ISSN or series number. Search by Title, ISBN, ISSN, Series Info Number (-) Remove Radionuclide therapy ...
68 Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial Several approaches based on positron emission tomography ...
Department of Nuclear Medicine, Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St, Jiangyang ...
Clinical trials involving [177Lu]Lu-RM2 and [177Lu]Lu-NeoB for targeted radionuclide treatment of prostate cancer have reported promising safety profiles and dosimetric results; the pancreas, with the ...
Molecular radiotherapy (MRT) is a rapidly growing field of minimally invasive cancer treatment within nuclear medicine. In recent years, its application, especially in prostate cancer therapy, has ...
As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...